Clin2
NCT06718972Likely a fitRecruiting

Lung cancer with brain lining spread: real-world treatment study

Meningeal MetastasisNon-Small Cell Lung Cancer

Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.

This study looks at how people with non-small cell lung cancer that has spread to the lining of the brain or spinal cord are treated in real-world clinics in China. If you have received treatment for this spread since 2018, you may be able to help doctors learn what works best.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
Any age
Study type
Observational

Who can take part

  • You have non-small cell lung cancer (the most common lung cancer type).
  • The cancer has spread to the lining of your brain or spinal cord (called leptomeningeal metastasis).
  • This spread was first found after January 2018.
  • You have already started treatment for the spread to your brain or spinal cord.
  • You do not have small cell lung cancer or any other type of cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06476093Recruiting
Radiation plus anlotinib for lung cancer brain spread

This trial tests a combination of focused radiation (stereotactic radiosurgery) and an oral targeted therapy called anlotinib for people with non-small cell lung cancer that has spread to the brain. It may offer a way to control brain metastases without more invasive procedures.

Lianyungang, Jiangsu
NCT07264569Recruiting· Phase 1/Phase 2
Testing a new drug for lung cancer that has spread to the brain or spinal fluid

This trial tests a new drug called BioTTT001 for people with non-small cell lung cancer (NSCLC) that has spread to the fluid around the brain or the lining of the brain (leptomeninges). The goal is to see if the drug is safe and can help control the cancer.

Zhengzhou, Henan
NCT06822543Recruiting· Phase 2
A new treatment for lung cancer that has spread to the brain

This trial tests a combination of three drugs (datopotamab deruxtecan, carboplatin, and pembrolizumab) for people with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to the brain and has not been treated before. The goal is to see if this combination can shrink tumors in the brain and elsewhere.

Fortaleza, Ceará
NCT06026735Recruiting
Lung cancer with brain spread: a surgical study

This trial looks at people with non-small cell lung cancer that has spread to the brain or the membranes around the brain. It aims to learn more about patients who are already scheduled for brain surgery, such as removing a tumor or placing a drain.

Taipei
NCT06638294Recruiting
Study for breast cancer spread to brain lining

This study is for people with breast cancer that has spread to the lining of the brain or spinal cord (called leptomeningeal metastasis). Researchers want to understand how to treat this condition and offer care to those who qualify.

Washington D.C., District of Columbia
NCT06705049Enrolling by invitation
Study on cancer spread to the lining of the brain

This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.

Shanghai

Hear when a new Meningeal Metastasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.